26,090 research outputs found
Recommended from our members
Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial.
AimsIn this analysis, we utilized data from PARADIGM-HF to test the hypothesis that participants who exhibited any dose reduction during the trial would have similar benefits from lower doses of sacubitril/valsartan relative to lower doses of enalapril.Methods and resultsIn a post-hoc analysis from PARADIGM-HF, we characterized patients by whether they received the maximal dose (200 mg sacubitril/valsartan or 10 mg enalapril twice daily) throughout the trial or had any dose reduction to lower doses (100/50/0 mg sacubitril/valsartan or 5/2.5/0 mg enalapril twice daily). The treatment effect for the primary outcome was estimated, stratified by dose level using time-updated Cox regression models. In the two treatment arms, participants with a dose reduction (43% of those randomized to enalapril and 42% of those randomized to sacubitril/valsartan) had similar baseline characteristics and similar baseline predictors of the need for dose reduction. In a time-updated analysis, any dose reduction was associated with a higher subsequent risk of the primary event [hazard ratio (HR) 2.5, 95% confidence interval (CI) 2.2-2.7]. However, the treatment benefit of sacubitril/valsartan over enalapril following a dose reduction was similar (HR 0.80, 95% CI 0.70-0.93, P < 0.001) to that observed in patients who had not experienced any dose reduction (HR 0.79, 95% CI 0.71-0.88, P < 0.001).ConclusionsIn PARADIGM-HF, study medication dose reduction identified patients at higher risk of a major cardiovascular event. The magnitude of benefit for patients on lower doses of sacubitril/valsartan relative to those on lower doses of enalapril was similar to that of patients who remained on target doses of both drugs
Energy Deposition in the Breast During CT Scanning: Quantification and Implications for Dose Reduction
Studies suggest that dose to the breast leads to a higher lifetime attributable cancer incidence risk from a chest CT scan for women compared to men. Numerous methods have been proposed for reducing dose to the breast during CT scanning, including bismuth shielding, tube current modulation, partial-angular scanning, and reduced kVp. These methods differ in how they alter the spectrum and fluence across projection angle. This study used Monte Carlo CT simulations of a voxelized female phantom to investigate the energy (dose) deposition in the breast as a function of both photon energy and projection angle. The resulting dose deposition matrix was then used to investigate several questions regarding dose reduction to the breast: (1) Which photon energies deposit the most dose in the breast, (2) How does increased filtration compare to tube current reduction in reducing breast dose, and (3) Do reduced kVp scans reduce dose to breast, and if so, by what mechanism? The results demonstrate that while high-energy photons deposit more dose per emitted photon, the low-energy photons deposit more dose to the breast for a 120 kVp acquisition. The results also demonstrate that decreasing the tube current for the AP views to match the fluence exiting a shield deposits nearly the same dose to the breast as when using a shield (within ~1%). Finally, results suggest that the dose reduction observed during lower kVp scans is caused by reduced photon fluence rather than the elimination of high-energy photons from the beam. Overall, understanding the mechanisms of dose deposition in the breast as a function of photon energy and projection angle enables comparisons of dose reduction methods and facilitates further development of optimized dose reduction schemes
CT dose reduction in children
World wide, the number of CT studies in children and the radiation exposure by CT increases. The same energy dose has a greater biological impact in children than in adults, and scan parameters have to be adapted to the smaller diameter of the juvenile body. Based on seven rules, a practical approach to paediatric CT is shown: Justification and patient preparation are important steps before scanning, and they differ from the preparation of adult patients. The subsequent choice of scan parameters aims at obtaining the minimal signal-to-noise ratio and volume coverage needed in a specific medical situation; exposure can be divided in two aspects: the CT dose index determining energy deposition per rotation and the dose-length product (DLP) determining the volume dose. DLP closely parallels the effective dose, the best parameter of the biological impact. Modern scanners offer dose modulation to locally minimise exposure while maintaining image quality. Beyond the selection of the physical parameters, the dose can be kept low by scanning the minimal length of the body and by avoiding any non-qualified repeated scanning of parts of the body. Following these rules, paediatric CT examinations of good quality can be obtained at a reasonable cost of radiation exposur
CT dose reduction factors in the thousands using X-ray phase contrast
Phase-contrast X-ray imaging can improve the visibility of weakly absorbing
objects (e.g. soft tissues) by an order of magnitude or more compared to
conventional radiographs. Previously, it has been shown that combining phase
retrieval with computed tomography (CT) can increase the signal-to-noise ratio
(SNR) by up to two orders of magnitude over conventional CT at the same
radiation dose, without loss of image quality. Our experiments reveal that as
radiation dose decreases, the relative improvement in SNR increases. We
discovered this enhancement can be traded for a reduction in dose greater than
the square of the gain in SNR. Upon reducing the dose 300 fold, the
phase-retrieved SNR was still almost 10 times larger than the absorption
contrast data. This reveals the potential for dose reduction factors in the
tens of thousands without loss in image quality, which would have a profound
impact on medical and industrial imaging applications
Changes in anti-viral effectiveness of interferon after dose reduction in chronic hepatitis C patients: a case control study
BACKGROUND: High dose interferon induction treatment of hepatitis C viral
infection blocks viral production over 95%. Since dose reduction is often
performed due to clinical considerations, the effect of dose reduction on
hepatitis C virus kinetics was studied. METHODS: A new model that allowed
longitudinal changes in the parameters of viral dynamics was used in a
group of genotype-1 patients (N = 15) with dose reduction from 10 to 3
million units of interferon daily in combination with ribavirin, in
comparison to a control group (N = 9) with no dose reduction. RESULTS:
Dose reduction gave rise to a complex viral kinetic pattern, which could
be only explained by a decrease in interferon effectiveness in blocking
virion production. The benefit of the rapid initial viral decline
following the high induction dose is lost after dose reduction. In
addition, in some patients also the second phase viral decline slope,
which is highly predictive of success of treatment, was impaired by the
dose reduction resulting in smaller percentage of viral clearance in the
dose reduction group. CONCLUSIONS: These findings, while explaining the
failure of many induction schedules, suggest that for genotype-1 patients
induction therapy should be continued till HCVRNA negativity in serum in
order to increase the sustained response rate for chronic hepatitis C
Transcriptional effects of gene dose reduction
Large-scale gene dose reductions usually lead to abnormal phenotypes or death. However, male mammals, Drosophila, and Caenorhabditis elegans have only one X chromosome and thus can be considered as monosomic for a major chromosome. Despite the deleterious effects brought about by such gene dose reduction in the case of an autosome, X chromosome monosomy in males is natural and innocuous. This is because of the nearly full transcriptional compensation for X chromosome genes in males, as opposed to no or partial transcriptional compensation for autosomal one-dose genes arising due to deletions. Buffering, the passive absorption of disturbance due to enzyme kinetics, and feedback responses triggered by expression change contribute to partial compensation. Feed-forward mechanisms, which are active responses to genes being located on the X, rather than actual gene dose are important contributors to full X chromosome compensation. In the last decade, high-throughput techniques have provided us with the tools to effectively and quantitatively measure the small-fold transcriptional effects of dose reduction. This is leading to a better understanding of compensatory mechanisms
Changes in anti-viral effectiveness of interferon after dose reduction in chronic hepatitis c patients: a case control study
BACKGROUND: High dose interferon induction treatment of hepatitis C viral infection blocks viral production over 95%. Since dose reduction is often performed due to clinical considerations, the effect of dose reduction on hepatitis C virus kinetics was studied. METHODS: A new model that allowed longitudinal changes in the parameters of viral dynamics was used in a group of genotype-1 patients (N = 15) with dose reduction from 10 to 3 million units of interferon daily in combination with ribavirin, in comparison to a control group (N = 9) with no dose reduction. RESULTS: Dose reduction gave rise to a complex viral kinetic pattern, which could be only explained by a decrease in interferon effectiveness in blocking virion production. The benefit of the rapid initial viral decline following the high induction dose is lost after dose reduction. In addition, in some patients also the second phase viral decline slope, which is highly predictive of success of treatment, was impaired by the dose reduction resulting in smaller percentage of viral clearance in the dose reduction group. CONCLUSIONS: These findings, while explaining the failure of many induction schedules, suggest that for genotype-1 patients induction therapy should be continued till HCVRNA negativity in serum in order to increase the sustained response rate for chronic hepatitis C
Coronary CT angiography: Dose reduction strategies
With the introduction of 64- and post-64 slice computed tomography (CT) technology, coronary CT angiography has been increasingly used as a less invasive modality for the diagnosis of coronary artery disease. Despite its high diagnostic value and promising results compared to invasive coronary angiography, coronary CT angiography is associated with high radiation dose, leading to potential risk of radiation-induced cancer. A variety of dose-reduction strategies have been reported recently to reduce radiation dose with effective outcomes having been achieved. This article presents an overview of the various methods currently used for radiation dose reduction
Patient dose reduction during voiding cystourethrography
Voiding cystourethrography (VCUG) is a commonly performed examination in a pediatric uroradiology practice. This article contains suggestions on how the radiation dose to a child from VCUG can be made ‘as low as reasonably achievable–(ALARA). The pediatric radiologist should consider the appropriateness of the clinical indication before performing VCUG and utilize radiation exposure techniques and parameters during VCUG to reduce radiation exposure to a child. The medical physicist and fluoroscope manufacturer can also work together to optimize a pulsed-fluoroscopy unit and further reduce the radiation exposure. Laboratory and clinical research is necessary to investigate methods that reduce radiation exposures during VCUG, and current research is presented here
- …